Skip to main content
. 2022 Aug 5;81:104335. doi: 10.1016/j.amsu.2022.104335

Table 3.

Outcome assessment and treatment received in the included studies.

No Author & years of publication Surgical Intervention NLR (mean ± SD) NLR Cut-off Cut-off point calculation Median OS Median CSS Primary Outcome Secondary Outcome
1 Kasuga et al., 2016 Radical Penectomy 5.03 ± 4.99 2.82 AUC NR NR OS, CSS LNM
2 Tan et al., 2017 Bilateral modified inguinal lymph node dissection or dynamic sentinel node biopsy 2.99 (0.76–5.22)∗∗ 2.8 AUC NR NR CSS, PFS, LNM
3 Azizi et al., 2018 Bilateral/unilateral inguinal lymph node dissection 4.51 ± 3.95 3 Contal and O'Quigley method 89 (31.2–123.6) months∗∗ NR OS, CSS, RFS LNM
4 Li et al., 2019 Bilateral inguinal lymph node dissection 2.4 (0.1–44.2) 2.6 ROC NR NR CSS LNM
5 Jiao Hu et al., 2020 Bilateral inguinal lymph node dissection after primary tumor procedure NR 3.59 ROC NR NR CSS LNM
6 Chen Hu et al., 2020 Inguinal lymph node dissection NR 2.94 AUC 34 (18–84) months∗∗ 33 (18–85.25) months∗∗ OS, PFS LNM
7 Jindal et al., 2021 Penectomy with bilateral inguinal node dissection NR 3 Following previous study by Azizi et al. NR 18 (2–74) months CSS LNM

NLR = Neutrophil-lymphocyte ratio, ROC = Receiver operating characteristic curve, AUC = Area under the curve, OS = Overall Survival, CSS = Cancer specific-survival, PFS = Progression-free survival, LNM = Lymph-Node Metastasis.

Data expressed as median and range.

∗∗

Data expressed as median and interquartile (IQR) range.